[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.239.157.140. Please contact the publisher to request reinstatement.
Article
June 20, 1959

USE OF ORALLY ADMINISTERED LIVE ATTENUATED POLIOVIRUSES AS A VACCINE IN A COMMUNITY SETTING: A CONTROLLED STUDY

Author Affiliations

Minneapolis

Secretary and Executive Officer (Dr. Barr); Director, Division of Medical Laboratories (Dr. Bauer); Chief, Section of Chronic Diseases (Dr. Kleinman); Chief, Section of Special Laboratory Studies, Division of Medical Laboratories (Dr. Kimball); Chief, Section of Viral and Rickettsial Diseases, Division of Medical Laboratories (Miss Cooney), Minnesota Department of Health; Assistant Professor, School of Public Health (Dr. Johnson) and Assistant Professor, Department of Pediatrics (Dr. Martins da Silva), University of Minnesota. Dr. Martins da Silva is now with the Pan American Sanitary Bureau, World Health Organization, Washington, D. C.

JAMA. 1959;170(8):893-905. doi:10.1001/jama.1959.03010080001001
Abstract

Attenuated strains of the three types of poliovirus were used in a study of 550 volunteer subjects. Subjects in group A received a placebo during the first 76 days of the study while those in group B received the polioviruses by mouth; during the remaining days (78th to 139th) group A received the viruses and group 8 the placebo. No particular type of symptom or reaction marked the entrance of the virus into the body. The children, and to a lesser extent the adults, receiving the virus manifested a generally increased titer of neutralizing antibody. The results for children and adults receiving the placebo were quite different. The positive responses occurred despite the fact that a substantial number of the participants had previously received Salk vaccine. Although the effectiveness of vaccination needs to be demonstrated finally in encounters with the disease itself, this study yielded strong evidence of the effectiveness as well as the safety of the living attenuated poliovirus used.

×